Kaori Saiki

Ehime University

Papers

1

Total Citations

1

H-Index

1

About

Dr. Kaori Saiki is a pioneering urologic surgeon whose work sits at the intersection of advanced robotics and immuno-oncology for renal cell carcinoma (RCC). Her research focuses on expanding the frontiers of minimally invasive surgery for complex, high-risk cases, particularly those involving inferior vena cava (IVC) tumor thrombi. Dr. Saiki’s major contribution is demonstrating the feasibility and safety of robot-assisted radical nephrectomy (RARN) with IVC thrombectomy following modern immunotherapy combinations. Her landmark 2024 case report—the first to document this procedure after pembrolizumab and axitinib therapy—provides a critical proof-of-concept for integrating neoadjuvant checkpoint inhibition with robotic surgical techniques. This work directly addresses a significant clinical gap, as patients with unresectable RCC historically had limited surgical options. While her most-cited paper currently holds 1 citation, its recency and pioneering nature signal its growing influence in urologic oncology. Dr. Saiki’s achievements represent a vital step toward personalized, multidisciplinary treatment pathways that combine the tumor-shrinking power of immunotherapy with the precision of robotic surgery, ultimately offering new hope for patients with locally advanced disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
A case report of robot-assisted radical nephrectomy and inferior vena cava thrombectomy in a patient with renal cell carcinoma after pembrolizumab and axitinib combination therapy
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Ehime University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago